Cargando…

Triple therapy after PCI – Warfarin treatment quality and bleeding risk

BACKGROUND: A combination of warfarin, aspirin and clopidogrel is indicated after percutaneous coronary intervention (PCI) in some patients, despite the higher risk of bleeding inferred by this triple therapy. OBJECTIVES: Whether the treatment quality of warfarin measured by iTTR (individual time wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wadell, Daniel, Jensen, Jens, Englund, Erling, Själander, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298652/ https://www.ncbi.nlm.nih.gov/pubmed/30562365 http://dx.doi.org/10.1371/journal.pone.0209187

Ejemplares similares

Predictors for INR-control in a well-managed warfarin treatment setting
por: Björck, Fredrik, et al.
Publicado: (2018)

Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
por: Brunetti, Natale Daniele, et al.
Publicado: (2020)

The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)
por: Eccleston, David S., et al.
Publicado: (2021)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study
por: Sjögren, Vilhelm, et al.
Publicado: (2017)

Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
por: Uygungül, Evren, et al.
Publicado: (2014)

Current strategies to minimize the bleeding risk of warfarin
por: Snipelisky, David, et al.
Publicado: (2013)

Balancing Between Ischemic and Bleeding Risk in PCI Patients With ‘Bi-Risk’
por: Park, Mahn-Won
Publicado: (2022)

Direct oral anticoagulants: patient reported adherence and minor bleedings
por: Hayat, Amina, et al.
Publicado: (2023)

Warfarin: Bleeding: case report
Publicado: (2021)

Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D
por: Welander, Frida, et al.
Publicado: (2022)

Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
por: Jansson, M., et al.
Publicado: (2023)

Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D
por: Welander, Frida, et al.
Publicado: (2023)

Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
por: Dannenberg, Lisa, et al.
Publicado: (2021)

Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
por: Yamamoto, Ko, et al.
Publicado: (2023)

Intestinal Tuberculosis Presenting with Gastrointestinal Bleeding in Patient on Warfarin Therapy
por: Kuka, Werimo Pascal, et al.
Publicado: (2022)

Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
por: Sherid, Muhammed, et al.
Publicado: (2016)

Does acupuncture increase the risk of bleeding in patients taking warfarin?
por: Leem, Jungtae
Publicado: (2015)

Thrombosis and Major Bleeding Risk After Primary PCI Among Patients With Multivessel Coronary Artery Disease
por: Zhao, Xiaoxiao, et al.
Publicado: (2022)

Predictive ability of scores for bleeding risk in heart disease outpatients on warfarin in Brazil
por: Oliveira, João Antonio de Queiroz, et al.
Publicado: (2018)

Warfarin: Major bleeding complication manifesting as retroperitoneal bleed: case report
Publicado: (2020)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding
por: Kang, Hye-Rim, et al.
Publicado: (2023)

No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI
por: Valgimigli, Marco, et al.
Publicado: (2020)

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
por: Teklay, Gebrehiwot, et al.
Publicado: (2014)

Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial
por: Nicolau, José C., et al.
Publicado: (2020)

Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective cohort study
por: Yagyuu, Takahiro, et al.
Publicado: (2017)

Warfarin: Bleeding from calciphylaxis wounds: case report
Publicado: (2022)

Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index
por: Dobies, David R, et al.
Publicado: (2015)

Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
por: Go, Alan S., et al.
Publicado: (2022)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
por: Charlton, Blake, et al.
Publicado: (2018)

Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study
por: Schelleman, Hedi, et al.
Publicado: (2011)

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
por: Abraham, Neena S, et al.
Publicado: (2015)

Post-polypectomy bleeding and thromboembolism risks associated with warfarin vs direct oral anticoagulants
por: Yanagisawa, Naohiro, et al.
Publicado: (2018)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Bleeding Complications in Warfarin-Treated Patients Admitted to the Emergency Department
por: Ozturk, Mustafa, et al.
Publicado: (2019)

Effect of warfarin discontinuation on the incidence of postoperative bleeding in tooth extraction
por: Lee, Jung-Soo, et al.
Publicado: (2020)

AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative
por: Puroll, Eric, et al.
Publicado: (2014)

Assessment of Risk Factors for Drug Resistance of Dual Anti Platelet Therapy After PCI
por: Zhang, Lijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qmgst6viqou01i3m7gsdkt3soo